報告題目：DNA酶促氧化在生長發(fā)育與疾病發(fā)生中的作用

報告時間：2023年3月29日（周三）下午14:00

報告地點：武漢大學生命科學學院二樓報告廳

報 告 人：徐國良 中國科學院院士

主講人簡介：

徐國良，中國科學院分子細胞科學卓越創(chuàng)新中心（生物化學與細胞生物學研究所）研究員，復旦大學生物醫(yī)學研究院教授兼執(zhí)行院長。1985年獲浙江大學生物學系學士學位、1988年獲中國科學院遺傳所碩士學位，1993年獲德國馬普分子遺傳學研究所博士學位。先后在德國馬普分子遺傳學研究所、美國哥倫比亞大學遺傳發(fā)育系和醫(yī)學系做博士后研究。2001至2006任中國科學院與德國馬普學會國際合作青年科學家小組組長，并獲得“國家杰出青年科學基金”，2015年當選中國科學院院士。

徐國良院士長期致力于DNA的表觀遺傳修飾研究，在“DNA甲基化與去甲基化的分子機制”以及“重編程過程中的表觀遺傳調(diào)控機制”研究領域取得一系列國際前沿和領先成果，兩次入選“中國科學十大進展”（2011年、2016年）。2012年獲得第五屆談家楨生命科學創(chuàng)新獎，2014年獲得陳嘉庚生命科學獎，2017年獲得何梁何利科學與技術進步獎。近年來主要探究表觀修飾及修飾酶在生長發(fā)育與腫瘤發(fā)生發(fā)展過程中的作用機制。

Brief Introduction of Professor Guoliang Xu

Guoliang Xu, research professor at the Center for Excellence in Molecular Cell Science, CAS, (Shanghai Institute of Biochemistry and Cell Biology), and professor and executive dean at the Biomedical Research Institute of Fudan University. He received his bachelor's degree from the Department of Biology at Zhejiang University in 1985, his master's degree from the Institute of Genetics, Chinese Academy of Sciences in 1988, and his PhD from the Max Planck Institute for Molecular Genetics in Germany in 1993. He did his postdoctoral research at the Max Planck Institute for Molecular Genetics in Germany, the Department of Genetics and Development at Columbia University in the United States, and the Department of Medicine at Columbia University. He served as the leader of the International Young Scientist Group of the Chinese Academy of Sciences and the Max Planck Society from 2001 to 2006, and was awarded the "The National Science Fund for Distinguished Young Scholars". He was elected as a member of the Chinese Academy of Sciences in 2015.

Academician Guoliang Xu has long been committed to the study of epigenetic modification of DNA. He has made a series of internationally leading achievements in the fields of "molecular mechanisms of DNA methylation and demethylation" and "epigenetic regulation mechanisms in reprogramming processes". His works have been twice selected as the "Top Ten Advances in Chinese Science" (2011 and 2016). He won the fifth C.C.Tan Life Science Innovation Award in 2012, the Tan Kah Kee Award of Life Sciences in 2014, and the Ho Leung Ho Lee Science and Technology Progress Award in 2017. His main interest recent years lies in the mechanism of epigenetic modification and modification enzymes in the process of growth and tumor development.